期刊文献+

人类乳头瘤病毒16型早期基因178位(T→G)突变分析

Analysis of the point mutation of high risk HPV16 early gene nt178(T→G)
下载PDF
导出
摘要 目的检测宫颈癌患者高危型人类乳头瘤病毒(human papillomavirus,HPV)16型阳性标本中早期基因(E6基因)178位(T→G)点突变情况。方法应用模板指导的染料终止子掺入-荧光偏振检测技术(TDI-FP)方法检测宫颈癌患者高危HPV16型E6基因178位点突变情况,以进一步明确此基因位点突变与宫颈癌变的相关性。结果应用TDI-FP法检测宫颈癌组织中高危HPV16型E6基因178位突变率为32.5%,与癌前病变及慢性宫颈炎患者相比,差异具有统计学意义(χ2=20.623,P<0.01)。结论宫颈癌患者HPV16型E6基因178位(T→G)突变率较高,可能是HPV致癌的一个高危因素。 Objective To detect the point mutation of high risk HPV16 early gene(E6) nt178(T→G) in cervical cancerous tissues.Methods We detected the point mutation of HPV16 E6 nt178 in the detected human papillomavirus(HPV) 16 positive cervical cancerous tissues by TDI-FP method so as to explain the correlation between the point mutation and cervical cancer.Results The HPV16 E6 nt178(T→G) point mutation rate was 32.5% in the present study.The point mutation rate of HPV16 E6 nt178 was significantly different from that of the control group(χ2=20.623,P0.01).Conclusion The point mutation rate of HPV16 E6 nt178 was higher in our study,which indicates that the point mutation of HPV16 E6 nt178 may promote the malignant process in cervical cancer patients and may be one of the cancer risk factors of HPV.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第6期773-777,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 陕西省科技计划资助项目[No.2007K09-08(2)]~~
关键词 人乳头瘤病毒 宫颈癌 荧光偏振 基因突变 human papillomavirus cervical cancer fluorescence polarization gene mutation
  • 相关文献

参考文献3

二级参考文献27

  • 1魏军,张正.人乳头瘤病毒PCR产物酶标-微孔板杂交分型[J].中华检验医学杂志,1998,22(3):41-43. 被引量:7
  • 2伍欣星,赵文先,丁晓华,苏应斌,丁红珍.湖北地区宫颈癌组织中人乳头瘤病毒16型E7基因的分离、克隆和序列分析[J].中国病毒学,1996,11(3):220-224. 被引量:11
  • 3Jastreboff AM, Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasis and malignancy.Postgrad Med J, 2002,78:225-228.
  • 4Kulasingam SL, Hughes JP, Kiviat NB, et 81. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities:comparison of sensitivity, specificity, and frequency of referral. JAMA,2002, 288: 1749-1757.
  • 5Wright JD, Herzog TJ. Human papillomavirus: emerging trends in detection and management. Current Womens Health Rep, 2002,2: 259-265.
  • 6Castle PE, Lorincz AT, Mielzynska-Lohnas I, et al. Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol, 2002.40:1088-1090.
  • 7Hsu TM, Chen X, Duan S, et al. Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques, 2001,31:560-568.
  • 8Song YS, Kee SH, Kim JW, et al. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women[J]. Gynecol Oncol, 1997; 66:275-281.
  • 9Vaeteewoottacharn K, Jearanaikoon P, Ponglikitmongkol M. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas[J]. Anticancer Res, 2003;23:1927-1931.
  • 10Edmonds C, Vousden KH. A point mutational analysis of human papillomavirus type 16 E7 protein[J]. J Virol, 1989; 63: 2650-2656.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部